Layton Patrick Mills
Founder presso CANNPAL ANIMAL THERAPEUTICS LIMITED
Profilo
Layton Patrick Mills is the founder of CannPal Animal Therapeutics Ltd., a company founded in 2016.
He holds the title of Chief Executive Officer, Director & MD at CannPal Animal Therapeutics Ltd.
Currently, Mr. Mills is a Non-Executive Director at Argent BioPharma Ltd., a position he started in 2023.
In the past, he served as the Chief Executive Officer at AusCann Group Holdings Ltd.
from 2021 to 2022.
Posizioni attive di Layton Patrick Mills
| Società | Posizione | Inizio |
|---|---|---|
| CANNPAL ANIMAL THERAPEUTICS LIMITED | Founder | 03/06/2016 |
| ARGENT BIOPHARMA LIMITED | Director/Board Member | 01/06/2023 |
Precedenti posizioni note di Layton Patrick Mills
| Società | Posizione | Fine |
|---|---|---|
| AUSCANN GROUP HOLDINGS LTD | Chief Executive Officer | 13/09/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ARGENT BIOPHARMA LIMITED | Health Technology |
| AUSCANN GROUP HOLDINGS LTD | Process Industries |
| Aziende private | 1 |
|---|---|
CannPal Animal Therapeutics Ltd.
 CannPal Animal Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology CannPal Animal Therapeutics Ltd. pharmaceutical company, which focuses on animal health. It researches, develops, and commercializes regulatory approved cannabinoid-derived therapeutic pet products for cats and dogs. The company was founded by Layton Mills on June 3, 2016 and is headquartered in Double Bay, Australia. | Health Technology |
- Borsa valori
- Insiders
- Layton Patrick Mills
